The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
Open accessAbstract
Biomarkers currently play an important role in the detection and management of patients with several different types of gastrointestinal cancer, especially colorectal, gastric, gastro‐oesophageal junction (GOJ) adenocarcinomas and gastrointestinal stromal tumors (GISTs). The aim of this article is to provide updated and evidence‐based guidelines for the use of biomarkers in the different gastrointestinal malignancies. Recommended biomarkers for colorectal cancer include an immunochemical‐based fecal occult blood test in screening asymptomatic subjects ≥50 years of age for neoplasia, serial CEA levels in postoperative surveillance of stage II and III patients who may be candidates for surgical resection or systemic therapy in the event of distant metastasis occurring, K‐RAS mutation status for identifying patients with advanced disease likely to benefit from anti‐EGFR therapeutic antibodies and microsatellite instability testing as a first‐line screen for subjects with Lynch syndrome. In advanced gastric or GOJ cancers, measurement of HER2 is recommended in selecting patients for treatment with trastuzumab. For patients with suspected GIST, determination of KIT protein should be used as a diagnostic aid, while KIT mutational analysis may be used for treatment planning in patients with diagnosed GISTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Grothey, A., Cutsem, E. V., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61900-x · Cited by 2,895
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Self-citationBlanke, C. D., Rankin, C., Demetri, G. D., Ryan, C. W., von Mehren, M., Benjamin, R. S., Raymond, A. K., Bramwell, V. H. C., Baker, L. H., Maki, R. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4452 · Cited by 1,073
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Simon, R. M., Paik, S., & Hayes, D. F. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp335 · Cited by 1,037
Hewitson, P., Glasziou, P., Watson, E., Towler, B., & Irwig, L. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01875.x · Cited by 990
Debiec-Rychter, M., Sciot, R., Le Cesne, A., Schlemmer, M., Hohenberger, P., van Oosterom, A. T., Blay, J.-Y., Leyvraz, S., Stul, M., Casali, P. G., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.030 · Cited by 892
[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 809
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
Self-citationDe Roock, W., Jonker, D. J., Di Nicolantonio, F., Sartore-Bianchi, A., Tu, D., Siena, S., Lamba, S., Arena, S., Frattini, M., Piessevaux, H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1535 · Cited by 748
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Bardelli, A., & Siena, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6116 · Cited by 746
Screening for colorectal cancer using the faecal occult blood test, Hemoccult
Hewitson, P., Glasziou, P. P., Irwig, L., Towler, B., & Watson, E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001216.pub2 · Cited by 742
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.97 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002) · BMJ · doi:10.1136/bmj.324.7341.813 · Cited by 651
Heinrich, M. C., Owzar, K., Corless, C. L., Hollis, D., Borden, E. C., Fletcher, C. D. M., Ryan, C. W., von Mehren, M., Blanke, C. D., Rankin, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.4284 · Cited by 641
European guidelines for quality assurance in colorectal cancer screening and diagnosis
Segnan, N., Patnick, J., & von Karsa, L. (2010) · Office for Official Publications of the European Communities eBooks · Cited by 641
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening
Allison, J. E., Tekawa, I. S., Ransom, L. J., & Adrain, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340304 · Cited by 622
American Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group
Compton, C., Fenoglio-Preiser, C. M., Pettigrew, N., & Fielding, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · Cited by 599
Bokemeyer, C., Cutsem, E. V., Rougier, P., Ciardiello, F., Heeger, S., Schlichting, M., Celik, I., & Köhne, C.-H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.057 · Cited by 585
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Moreira, L., Balaguer, F., Lindor, N., de la Chapelle, A., Hampel, H., Aaltonen, L. A., Hopper, J. L., Le Marchand, L., Gallinger, S., Newcomb, P. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.13088 · Cited by 556
Elsaleh, H., Joseph, D., Grieu, F., Zeps, N., Spry, N., & Iacopetta, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02261-3 · Cited by 552
Pignone, M., Saha, S., Hoerger, T., & Mandelblatt, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00007 · Cited by 538
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., Westerga, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1077 · Cited by 537
Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Holinski-Feder, E., Klapdor, R., Lamerz, R., Peltomaki, P., Sturgeon, C., & Topolcan, O. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.021 · Cited by 506
Self-citationRüschoff, J., Dietel, M., Baretton, G., Arbogast, S., Walch, A., Monges, G., Chenard, M.-P., Penault-Llorca, F., Nagelmeier, I., Schlake, W., et al. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0952-2 · Cited by 486
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Debiec-Rychter, M., Dumez, H., Judson, I., Wasag, B., Verweij, J., Brown, M., Dimitrijevic, S., Sciot, R., Stul, M., Vranck, H., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.025 · Cited by 444
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Warren, J. D., Xiong, W., Bunker, A. M., Vaughn, C. P., Furtado, L. V., Roberts, W. L., Fang, J. C., Samowitz, W. S., & Heichman, K. A. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-133 · Cited by 438
Cost-effectiveness of colorectal cancer screening – An overview
Lansdorp-Vogelaar, I., Knudsen, A. B., & Brenner, H. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.04.004 · Cited by 438
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
Goldstein, M. J., & Mitchell, E. P. (2005) · Cancer Investigation · doi:10.1081/cnv-58878 · Cited by 419
Verweij, J., van Oosterom, A., Blay, J.-Y., Judson, I., Rodenhuis, S., van der Graaf, W., Radford, J., Le Cesne, A., Hogendoorn, P. C. W., di Paola, E. D., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00836-5 · Cited by 404
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
Figueredo, A., Rumble, R. B., Maroun, J., Earle, C. C., Cummings, B., McLeod, R., Zuraw, L., Zwaal, C., & the members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care (2003) · BMC Cancer · doi:10.1186/1471-2407-3-26 · Cited by 392 · cited 1×
“Despite this, regular measurement of CEA, as part of an intensive follow-up regime, appears to be necessary to achieve significant improvement in survival.(44,48,49) Compared to other available diagnostic modalities, serial CEA determinations appear to be the most sensitive for the detection of early recurrent disease…”
BackgroundGuastadisegni, C., Colafranceschi, M., Ottini, L., & Dogliotti, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.009 · Cited by 380
Gray, R. G., Quirke, P., Handley, K., Lopatin, M., Magill, L., Baehner, F. L., Beaumont, C., Clark-Langone, K. M., Yoshizawa, C. N., Lee, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8732 · Cited by 380
Clinical utility of biochemical markers in colorectal cancer
Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Klapdor, R., Lamerz, R., Nilsson, O., Sturgeon, C., & Topolcan, O. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00811-0 · Cited by 374
Self-citationAllison, J. E., Sakoda, L. C., Levin, T. R., Tucker, J. P., Tekawa, I. S., Cuff, T., Pauly, M. P., Shlager, L., Palitz, A. M., Zhao, W. K., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm150 · Cited by 372
Tejpar, S., Celik, I., Schlichting, M., Sartorius, U., Bokemeyer, C., & Van Cutsem, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2592 · Cited by 353
Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version
Nishida, T., Hirota, S., Yanagisawa, A., Sugino, Y., Minami, M., Yamamura, Y., Otani, Y., Shimada, Y., Takahashi, F., & Kubota, T. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0798-7 · Cited by 353
Hemminki, A., Mecklin, J., Järvinen, H., Aaltonen, L. A., & Joensuu, H. (2000) · Gastroenterology · doi:10.1053/gast.2000.18161 · Cited by 352
Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis
Tjandra, J. J., & Chan, M. K. Y. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9030-5 · Cited by 342
Ladabaum, U., Wang, G., Terdiman, J., Blanco, A., Kuppermann, M., Boland, C. R., Ford, J., Elkin, E., & Phillips, K. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-2-201107190-00002 · Cited by 340
Labianca, R., Nordlinger, B., Beretta, G. D., Brouquet, A., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq168 · Cited by 340
Clinical Relevance of Microsatellite Instability in Colorectal Cancer
de la Chapelle, A., & Hampel, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0652 · Cited by 332
Follow-Up of Patients with Colorectal Cancer A Meta-Analysis
Bruinvels, D. J., Stiggelbout, A. M., Kievit, J., van Houwellngen, H. C., F. Habbema, J. D., & van de Velde, C. J. H. (1994) · Annals of Surgery · doi:10.1097/00000658-199402000-00009 · Cited by 322
Decrease in Mortality in Lynch Syndrome Families Because of Surveillance
de Jong, A. E., Hendriks, Y. M. C., Kleibeuker, J. H., de Boer, S. Y., Cats, A., Griffioen, G., Nagengast, F. M., Nelis, F. G., Rookus, M. A., & Vasen, H. F. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.032 · Cited by 302
Des Guetz, G., Schischmanoff, O., Nicolas, P., Perret, G.-Y., Morere, J.-F., & Uzzan, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.018 · Cited by 291
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Roth, A. D., Delorenzi, M., Tejpar, S., Yan, P., Klingbiel, D., Fiocca, R., d'Ario, G., Cisar, L., Labianca, R., Cunningham, D., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs427 · Cited by 284
PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors.
Kopetz, S., Desai, J., Chan, E., Hecht, J. R., O'Dwyer, P. J., Lee, R. J., Nolop, K. B., & Saltz, L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.3534 · Cited by 283
(2012) · Annals of Oncology · doi:10.1093/annonc/mds252 · Cited by 281
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Brand, T. M., Iida, M., & Wheeler, D. L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15050 · Cited by 273
Vasen, H. F. A., Abdirahman, M., Brohet, R., Langers, A. M. J., Kleibeuker, J. H., van Kouwen, M., Koornstra, J. J., Boot, H., Cats, A., Dekker, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.053 · Cited by 242
Mismatch repair deficient colorectal cancer in the era of personalized treatment
Hewish, M., Lord, C. J., Martin, S. A., Cunningham, D., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.18 · Cited by 235
Schmoll, H.-J., Cunningham, D., Sobrero, A., Karapetis, C. S., Rougier, P., Koski, S. L., Kocakova, I., Bondarenko, I., Bodoky, G., Mainwaring, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.5355 · Cited by 213
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M., Cubiella, J., Balaguer, F., Sempere, L., Xicola, R. M., Bujanda, L., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.016 · Cited by 197
Fujimoto-Ouchi, K., Sekiguchi, F., Yasuno, H., Moriya, Y., Mori, K., & Tanaka, Y. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0337-z · Cited by 193
Follow-up of colorectal cancer: A meta-analysis
Rosen, M., Chan, L., Beart, R. W., Vukasin, P., & Anthone, G. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02239433 · Cited by 192
Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening
Lansdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A. G., Habbema, J. D. F., & Kuipers, E. J. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp319 · Cited by 191
Pérez-Carbonell, L., Ruiz-Ponte, C., Guarinos, C., Alenda, C., Payá, A., Brea, A., Egoavil, C. M., Castillejo, A., Barberá, V. M., Bessa, X., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300041 · Cited by 191
Kennedy, R. D., Bylesjo, M., Kerr, P., Davison, T., Black, J. M., Kay, E. W., Holt, R. J., Proutski, V., Ahdesmaki, M., Farztdinov, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.4498 · Cited by 190
TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer
Ebert, M. P. A., Tänzer, M., Balluff, B., Burgermeister, E., Kretzschmar, A. K., Hughes, D. J., Tetzner, R., Lofton-Day, C., Rosenberg, R., Reinacher-Schick, A. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009473 · Cited by 189
Mao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Bertagnolli, M. M., Redston, M., Compton, C. C., Niedzwiecki, D., Mayer, R. J., Goldberg, R. M., Colacchio, T. A., Saltz, L. B., & Warren, R. S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0092 · Cited by 188
Park, Y. J., Park, K. J., Park, J., Lee, K. U., Choe, K. J., & Kim, J. (1999) · World Journal of Surgery · doi:10.1007/pl00012376 · Cited by 182
Graham, R. A., Wang, S., Catalano, P. J., & Haller, D. G. (1998) · Annals of Surgery · doi:10.1097/00000658-199807000-00009 · Cited by 176
Thirunavukarasu, P., Sukumar, S., Sathaiah, M., Mahan, M., Pragatheeshwar, K. D., Pingpank, J. F., Zeh, H., Bartels, C. J., Lee, K. K. W., & Bartlett, D. L. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr078 · Cited by 175
Karsa, L., Patnick, J., & Segnan, N. (2012) · Endoscopy · doi:10.1055/s-0032-1309822 · Cited by 173
Dahabreh, I. J., Terasawa, T., Castaldi, P. J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00006 · Cited by 172
Sugarbaker, P. H., Gianola, F. J., Dwyer, A. A., & Neuman, N. (1987) · PubMed · Cited by 172
A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
Fraser, C. G., Allison, J. E., Halloran, S. P., Young, G. P., & on behalf of the Expert Working Group on Fecal Immunochemical Tests for Hemoglobin, C. C. S. C. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs190 · Cited by 162
Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation
Heitman, S. J., Hilsden, R. J., Au, F., Dowden, S. D., & Manns, B. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000370 · Cited by 146
Weissman, S. M., Burt, R. W., Church, J. M., Erdman, S., Hampel, H., Holter, S., Jasperson, K. W., Kalady, M. F., Haidle, J. L., Lynch, H. T., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9465-7 · Cited by 132
The GIST paradigm: lessons for other kinase‐driven cancers
Antonescu, C. R. (2010) · The Journal of Pathology · doi:10.1002/path.2798 · Cited by 124
A preclinical and clinical review of aflibercept for the management of cancer
Gaya, A. M., & Tse, V. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.12.008 · Cited by 119
Renehan, A. G., O', S. T. D., & Whynes, D. K. (2004) · BMJ · doi:10.1136/bmj.328.7431.81 · Cited by 112
Sun, L., Chu, K., Cheng, S.-C., Lu, C.-Y., Kuo, C., Hsieh, J., Shih, Y., Chang, S., & Wang, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-288 · Cited by 111
Duffy, M. J., van Rossum, L. G. M., van Turenhout, S. T., Malminiemi, O., Sturgeon, C., Lamerz, R., Nicolini, A., Haglund, C. H., Holubec, L., Fraser, C. G., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25654 · Cited by 111
Self-citationTsikitis, V. L., Malireddy, K., Green, E. A., Christensen, B. J., Whelan, R. L., Hyder, J. W., Marcello, P. W., Larach, S. W., Lauter, D. M., Sargent, D. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7050 · Cited by 111
Serum tumour markers: how to order and interpret them
Sturgeon, C. M., Lai, L., & Duffy, M. J. (2009) · BMJ · doi:10.1136/bmj.b3527 · Cited by 110
Self-citationCEA Serum Levels in Non-Neoplastic Disease
Morell, Á. R. (1992) · The International Journal of Biological Markers · doi:10.1177/172460089200700307 · Cited by 108
Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
Win, A. K., Lindor, N. M., Winship, I., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs525 · Cited by 106
Molecular Tests for Colorectal Cancer Screening
Bosch, L. J. W., Carvalho, B. G., Fijneman, R. J. A., Jiménez, C. R., Pinedo, H. M., van Engeland, M., & Meijer, G. A. (2011) · Clinical Colorectal Cancer · doi:10.3816/ccc.2011.n.002 · Cited by 101
Zhu, M., Xi Tao, X. U., Nie, F., Tong, J. L., Shu Dong, X. I. A. O., & Ran, Z. H. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00430.x · Cited by 95
Martinelli, E., Troiani, T., D'Aiuto, E., Morgillo, F., Vitagliano, D., Capasso, A., Costantino, S., Ciuffreda, L. P., Merolla, F., Vecchione, L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28236 · Cited by 92
Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer
Yakabe, T., Nakafusa, Y., Sumi, K., Miyoshi, A., Kitajima, Y., Sato, S., Noshirο, H., & Miyazaki, K. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1004-5 · Cited by 89
van Rossum, L. G. M., van Rijn, A. F., Verbeek, A. L. M., van Oijen, M. G. H., Laheij, R. J. F., Fockens, P., Jansen, J. B. �. �., Adang, E., & Dekker, E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25530 · Cited by 80
Surveillance after Curative Resection of Colorectal Cancer
Scheer, A. S., & Auer, R. C. (2009) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0029-1242464 · Cited by 79
Ng, K., Tabernero, J. M., Hwang, J. J., Bajetta, E., Sharma, S., Prete, S. A. D., Arrowsmith, E. R., Ryan, D. P., Šedová, M., Jin, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0027 · Cited by 75
Berger, B. M., & Ahlquist, D. A. (2011) · Pathology · doi:10.1097/pat.0b013e3283502fdf · Cited by 75
Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors
Blay, J., von Mehren, M., & Blackstein, M. E. (2010) · Cancer · doi:10.1002/cncr.25267 · Cited by 67
Spreafico, A., Tentler, J. J., Pitts, T. M., Tan, A. C., Gregory, M. A., Arcaroli, J. J., Klauck, P. J., McManus, M. C., Hansen, R. J., Kim, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3140 · Cited by 66
Vijayaraghavan, A., Efrusy, M. B., Göke, B., Kirchner, T., Santas, C. C., & Goldberg, R. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26400 · Cited by 64
Strimpakos, A. S., Cunningham, D., Mikropoulos, C., Petkar, I., Barbáchano, Y., & Chau, I. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp449 · Cited by 59
Nicolini, A. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.251 · Cited by 55
Self-citationLinardou, H., Briasoulis, E. C., Dahabreh, I. J., Mountzios, G., PAPADIMITRIOU, C. A., Papadopoulos, S., Bafaloukos, D. I., Kosmidis, P., & Murray, S. J. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.008 · Cited by 54
de Haas, R. J., Wicherts, D. A., Flores, E., Ducreux, M. P., Lévi, F., Paule, B., Azoulay, D., Castaing, D., Lemoine, A., & Adam, R. A. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0887-5 · Cited by 50
Chao, M., & Gibbs, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6156 · Cited by 46
EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
Grothey, A. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.3407 · Cited by 44
Loupakis, F., Cremolini, C., Salvatore, L., Schirripa, M., Lonardi, S., Vaccaro, V., Cuppone, F., Giannarelli, D., Zagonel, V., Cognetti, F., et al. (2011) · Cancer · doi:10.1002/cncr.26460 · Cited by 41
Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer
Ailawadhi, S., Sunga, A. Y., Rajput, A., Yang, G., Smith, J. L., & Fakih, M. (2006) · Oncology · doi:10.1159/000091184 · Cited by 35
Stein, A., Glockzin, G., Wienke, A., Arnold, D., Edelmann, T., Hildebrandt, B., Hollerbach, S. H., Illerhaus, G., Königsrainer, A., Richter, M., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-356 · Cited by 27
Grazzini, G., Ciatto, S., Cislaghi, C., Castiglione, G., Falcone, M. A., Mantellini, P., & Zappa, M. (2008) · Journal of Medical Screening · doi:10.1258/jms.2008.008032 · Cited by 27
Ballestrero, A., Garuti, A., Cirmena, G., Rocco, I., Palermo, C., Nencioni, A., Scabini, S., Zoppoli, G. M., Parodi, S., & Patrone, F. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800190956 · Cited by 24
Bevacizumab in colorectal cancer: current and future directions
Yeung, Y. H., & Tebbutt, N. C. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.104 · Cited by 23
A future for faecal haemoglobin measurements in the medical laboratory
Fraser, C. G. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012065 · Cited by 23
Lynch syndrome diagnostics: decision-making process for germ-line testing
Lastra, E., García-González, M. A., Llorente, B., Bernuy, C., Barrio, M. J., Pérez‐Cabornero, L., Durán, M., & Girón, C. G. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0793-3 · Cited by 2
Cited by
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., Seligmann, J., De Baere, T., Osterlund, P., Yoshino, T., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.003 · Cited by 1,796
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041
Duffy, M. J., Harbeck, N., Nap, M., Molina, R., Nicolini, A., Senkus, E., & Cardoso, F. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.01.017 · Cited by 522
Self-citationColorectal cancer tumour markers and biomarkers: Recent therapeutic advances
Lech, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i5.1745 · Cited by 419
Zhang, Q., Jeppesen, D. K., Higginbotham, J. N., Graves-Deal, R., Trinh, V. Q., Ramirez, M. A., Sohn, Y., Neininger, A. C., Taneja, N., McKinley, E. T., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00805-8 · Cited by 419
Metadata
- Authors
- Duffy, M. J., Lamerz, R., Haglund, C., Nicolini, A., Kalousová, M., Holubec, L., & Sturgeon, C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-08-27
- Volume
- 134
- Issue
- 11
- Pages
- 2513-2522
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1539249527
- Cited by
- 360
- References
- 126
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.